The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-(3-(Dimethylamino)propyl)-6-o-tolyl-1H-pyrazolo[3,4-b]-pyridine-4-carboxamide ID: ALA4762323
PubChem CID: 162660246
Max Phase: Preclinical
Molecular Formula: C19H23N5O
Molecular Weight: 337.43
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: Cc1ccccc1-c1cc(C(=O)NCCCN(C)C)c2cn[nH]c2n1
Standard InChI: InChI=1S/C19H23N5O/c1-13-7-4-5-8-14(13)17-11-15(16-12-21-23-18(16)22-17)19(25)20-9-6-10-24(2)3/h4-5,7-8,11-12H,6,9-10H2,1-3H3,(H,20,25)(H,21,22,23)
Standard InChI Key: VSNYQXWGDVPYHI-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 27 0 0 0 0 0 0 0 0999 V2000
4.7490 -5.4727 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7479 -6.2922 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4559 -6.7012 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.4541 -5.0638 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0417 -6.7005 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3341 -6.2897 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6265 -6.6970 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6254 -7.5151 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3378 -7.9241 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0424 -7.5144 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3356 -5.4725 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4517 -4.2466 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1582 -3.8359 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.7428 -3.8401 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.1628 -5.4691 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1630 -6.2877 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9417 -6.5404 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.4227 -5.8780 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.9412 -5.2159 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1557 -3.0187 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8622 -2.6080 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8598 -1.7908 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5663 -1.3801 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.5638 -0.5629 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.2752 -1.7866 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 16 2 0
15 4 2 0
4 1 1 0
5 6 2 0
6 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 5 1 0
2 5 1 0
6 11 1 0
4 12 1 0
12 13 1 0
12 14 2 0
15 16 1 0
16 17 1 0
17 18 1 0
18 19 2 0
19 15 1 0
13 20 1 0
20 21 1 0
21 22 1 0
22 23 1 0
23 24 1 0
23 25 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 337.43Molecular Weight (Monoisotopic): 337.1903AlogP: 2.61#Rotatable Bonds: 6Polar Surface Area: 73.91Molecular Species: BASEHBA: 4HBD: 2#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 10.02CX Basic pKa: 9.21CX LogP: 1.74CX LogD: 0.25Aromatic Rings: 3Heavy Atoms: 25QED Weighted: 0.68Np Likeness Score: -1.75
References 1. Cowen SD,Russell D,Dakin LA,Chen H,Larsen NA,Godin R,Throner S,Zheng X,Molina A,Wu J,Cheung T,Howard T,Garcia-Arenas R,Keen N,Pendleton CS,Pietenpol JA,Ferguson AD. (2016) Design, Synthesis, and Biological Activity of Substrate Competitive SMYD2 Inhibitors., 59 (24): [PMID:28002961 ] [10.1021/acs.jmedchem.6b01303 ]